Proteomics unite traditional toxicological assessment methods to evaluate the toxicity of iron oxide nanoparticles

Iron oxide nanoparticles (IONPs) are the first generation of nanomaterials approved by the Food and Drug Administration for use as imaging agents and for the treatment of iron deficiency in chronic kidney disease. However, several IONPs-based imaging agents have been withdrawn because of toxic effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Junyuan, Tian, Yongzhang, Wang, Minghan, Li, Yajuan, Yin, Jiye, Qu, Wensheng, Yan, Changhui, Ding, Rigao, Guan, Yongbiao, Wang, Quanjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512491/
https://www.ncbi.nlm.nih.gov/pubmed/36172182
http://dx.doi.org/10.3389/fphar.2022.1011065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512491/
https://www.ncbi.nlm.nih.gov/pubmed/36172182
http://dx.doi.org/10.3389/fphar.2022.1011065

Ejemplares similares